Table 1 Clinicopathological characteristics of bladder cancer
From: LINC00958 promotes bladder cancer carcinogenesis by targeting miR-490-3p and AURKA
Clinicopathological characteristics | N (%) |
|---|---|
Total | 34 |
Age (year) | |
 >60 | 19 (55.88) |
  ≤ 60 | 15 (44.12) |
Sex | |
 Male | 27 (79.41) |
 Female | 7 (20.59) |
Smoking | |
 Yes | 16 (47.06) |
 No | 18 (52.94) |
Grading | |
 G1 | 8 (23.53) |
 G2 | 13 (38.24) |
 G3 | 11(32.35) |
 G4 | 1 (2.94) |
 n.a. | 1 (2.94) |
Tumor size (cm) | |
  < 3 | 15 (44.12) |
  ≥ 3 | 19 (55.88) |
Tumor number | |
 1 | 26 (76.47) |
 2–7 | 5 (14.71) |
  ≥ 8 | 1 (2.94) |
 Not specified | 2 (5.88) |
Alguria | |
 Yes | 11 (32.35) |
 No | 23 (67.65) |